131 related articles for article (PubMed ID: 11693272)
21. Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice.
Ukai M; Shinkai N; Kameyama T
Eur J Pharmacol; 1998 May; 350(1):39-45. PubMed ID: 9683012
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
[TBL] [Abstract][Full Text] [Related]
23. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
Starr MS; Starr BS
Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol.
Joel D; Avisar A; Doljansky J
Behav Neurosci; 2001 Dec; 115(6):1291-300. PubMed ID: 11770060
[TBL] [Abstract][Full Text] [Related]
25. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat.
Silvestre JS; O'Neill MF; Fernandez AG; Palacios JM
Eur J Pharmacol; 1996 Dec; 318(2-3):257-65. PubMed ID: 9016913
[TBL] [Abstract][Full Text] [Related]
26. Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice.
Ukai M; Lin HP
Eur J Pharmacol; 2002 Jun; 446(1-3):97-101. PubMed ID: 12098590
[TBL] [Abstract][Full Text] [Related]
27. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
Dreher JK; Jackson DM
Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
[TBL] [Abstract][Full Text] [Related]
28. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
Rogoz R; Dziedzicka-Wasylewska M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304
[TBL] [Abstract][Full Text] [Related]
29. Involvement of D1 dopamine receptor mechanism in ischemia-induced impairment of CA1 presynaptic fiber spikes in rat hippocampal slices.
Yamamoto Y; Tanaka T; Shibata S; Watanabe S
Brain Res; 1994 Nov; 665(1):151-4. PubMed ID: 7882009
[TBL] [Abstract][Full Text] [Related]
30. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
[TBL] [Abstract][Full Text] [Related]
31. Facilitation and disruption of memory for the passive avoidance task in the day-old chick using dopamine D1 receptor compounds.
Hale MW; Crowe SF
Behav Pharmacol; 2003 Nov; 14(7):525-32. PubMed ID: 14557720
[TBL] [Abstract][Full Text] [Related]
32. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Cho S; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
[TBL] [Abstract][Full Text] [Related]
33. Regulation of c-Fos and NGF1-A by antidepressant treatments.
Morinobu S; Strausbaugh H; Terwilliger R; Duman RS
Synapse; 1997 Apr; 25(4):313-20. PubMed ID: 9097389
[TBL] [Abstract][Full Text] [Related]
34. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
Itoh T; Tokumura M; Abe K
Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
[TBL] [Abstract][Full Text] [Related]
35. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
37. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
Evans AM; Green KL
Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
[TBL] [Abstract][Full Text] [Related]
38. Dopaminergic modulation of rat pup ultrasonic vocalizations.
Dastur FN; McGregor IS; Brown RE
Eur J Pharmacol; 1999 Oct; 382(2):53-67. PubMed ID: 10528139
[TBL] [Abstract][Full Text] [Related]
39. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of D1 and D2 dopamine-receptor agonists and antagonists on appetitive and consummatory aspects of male sexual behavior in Japanese quail.
Balthazart J; Castagna C; Ball GF
Physiol Behav; 1997 Sep; 62(3):571-80. PubMed ID: 9272666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
